Hepatocellular carcinoma: Strategy for optimizing surgical resection, transplantation and palliation

Clinical Transplantation

Volumn 16, Issue SUPPL. 7, 2002, Pages 52-58

  Fisher, Robert A ^a   Maroney, Timothy P ^a   Fulcher, Ann S ^a   Maluf, Daniel ^a   Clay, John A ^a   Wolfe, Luke G ^a   Dawson III, Sheffield ^a   Cotterell, Adrian ^a   Stravitz, R Todd ^a   Luketic, Velimir A ^a   Shiftman, Mitchell ^a   Sterling, Richard K ^a   Posner, Marc P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ablation; Chemo infusion; Hepatocellular cancer; Resection; Transplant

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BONE SCINTISCANNING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADULT; CRYOTHERAPY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LIVER TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; TUMOR RECURRENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; CRYOTHERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PROSPECTIVE STUDIES;

EID: 1942485659     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.16.s7.8.x     Document Type: Article

References (31)

1. EL-SERAG HB, MASON AC. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med 1999: 340: 745.
2. KLINTMALM GB. Liver transplantation for hepatocellular carcinoma. A registry report on the impact of tumor characteristics on outcome. Ann Surg 1998: 228 (4): 479.
3. FIGUERAS J, JAURRIETA E, VALLS C et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. Am Coll Surg 2000: 190 (5): 580.
4. IWATSUKI S, DVORCHIK I, MARSH JW et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000: 191 (5): 389.
5. FISHER RA, ANDERSON ML, HAM JM et al. Hepatocellular carcinoma ablative regimen for optimizing surgical resection, transplant, and palliation. Am J Transplantation 2001: 1 (1): 426.
6. UNITED NETWORK FOR ORGAN SHARING. Policy 3.6, 3.6.4.4, Allocation of livers. LI Status 2B Justification form 898, 1998.
7. MARANO I, DELLANOCE M, STAGNI V et al. Magnetic resonance in surgical planning in hepatocarcinomas. Radiol Med 1995: 89 (1): 94.
8. FULCHER AS, TURNER MA, CAPPS GW, ZFASS AM, BAKER KM. Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiol 1998: 207: 21.
9. AMERICAN LIVER TUMOR STUDY GROUP. A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigators Booklet and Protocol, 1998. United Network for Organ Sharing. Policy 3.6.4.4. 1998.
10. FISHER RA, HAM JM, MARCOS A et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998: 66 (12): 1616.
11. HARADA T, MATSUO K, INOUE T, TAMESUE S, INOUE TO, NAKAMURA H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellulaar carcinoma? Ann Surg 1996: 224 (1): 4.
12. SCHLITT HJ, NEIPP M, WEIMANN A et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999: 17 (1): 324.
13. NEIFELD JP. Hepatic cryotherapy. MDNEWS 1998: 1: 1.
14. PEARSON AS, IZZO F, FLEMING D et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999: 178: 592.
15. DODD G, HAL G, RHIM H, CHINTAPALLI KN, CHOPRA S, ESOLA C. Ultrasound guided radiofrequency thermal ablation of hepatic tumors. Annual San Antonio Cancer Symposium in San Antonio, TX July 25, 1997.
16. ACHKOR JP, ARAYA V, BARON RL, MARSH HW, DVORCHIK I, RAKELA J. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg 1998: 4: 477.
17. SCHWARTZ ME, SUNG M, MOR E et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995: 180: 596.
18. FIGUERAS J, JAURRIETA E, VALLIS C et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997: 25 (6): 1485.
19. MAZZAFERRO V, REGALIA E, DOCI R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Eng J Med 1996: 334 (11): 693.
20. MAZZAFERRO V, RHONDINARA GF, ROSSI G et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994: 26 (6): 3557.
21. BRUIX J, LLOVET JM, CASTELLS A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998: 27: 1578.
22. GETCH. A comparison of lipiodol chemoembolization in European patients with unresectable hepatocellular carcinoma. N Engl J Med 1995: 332: 1256.
23. HARNOIS DM, STEERS J, ANDREWS JC et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999: 5 (3): 192.
24. COTELLA G, BOTTELLI R, DE CARLIS L et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transplantation Int 1998: 11 (1): 5193.
25. OKUDA K, TANAKA M, SHIBATA J et al. Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluoruracil for multiple recurrence of hepatocellular carcinoma after surgical treatment. Oncol Report 1999: 6 (3): 587.
26. WANG ZY, SHI ZH, ZAI RY. Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma. Chunghua Chung Liu Tsa Chih 1994: 16 (6): 454.
27. MARSH JW, DVORCHIK I, BONHAM CA, IWATSUKI S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000: 88 (3): 538.
28. ROSE DM, CHAPMAN WC, BROCKENBROUGH AT et al. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999: 177 (5): 405.
29. SHIMADA M, GION T, HARNATSU T et al. Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepatogastroenterology 1999: 46 (25): 401.
30. NAGAO T, INOUE S, GOTO S, et al. Hepatic resection for hepatocellular carcinoma, clinical features and long-term prognosis. Ann Surg 1987: 205 (1): 33.
31. YAMAMOTO J, IWATSUKIS KOSUGE T, DVORCHIK I, SHIMADA K, MARSH JW, YAMASAKIS STARZL TE. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999: 86 (7): 1151.